TOFACITINIB IMPROVES DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES (PROS) IN PATIENTS (PTS) WITH ACTIVE PSORIATIC ARTHRITIS (PSA) IN REAL CLINICAL PRACTICE.

被引：1
|
作者：
Korotaeva, T. [1 ]
Vorobyova, L. [1 ]
Loginova, E. [1 ]
Gubar, E. [1 ]
Korsakova, Y. [1 ]
Glukhova, S. [1 ]
Karpova, P. [1 ]
机构：
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.2620
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0845
引用
收藏
页码：1725 / 1725
页数：1
相关论文
共 50 条
  • [1] EFFECT OF FATIGUE ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES (PROS) IN PATIENTS (PTS) WITH PSORIATIC ARTHRITIS (PSA)
    Vorobyova, L.
    Korotaeva, T.
    Loginova, E.
    Korsakova, Y.
    Gubar, E.
    Tremaskina, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1327 - 1328
  • [2] COMPARATIVE EFFECTIVENESS OF TOFACITINIB (TF) AND ADALIMUMAB (ADA) IN PSORIATIC ARTHRITIS (PSA) PATIENTS IN REAL CLINICAL PRACTICE.
    Loginova, E.
    Korotaeva, T.
    Gubar, E.
    Korsakova, Y.
    Glukhova, S.
    Vasilenko, E.
    Vasilenko, A.
    Kuznetsova, N.
    Patrikeeva, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1164 - 1164
  • [3] Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
    Gladman, Dafna D.
    Coates, Laura C.
    Wu, Joseph
    Fallon, Lara
    Bacci, Elizabeth D.
    Cappelleri, Joseph C.
    Bushmakin, Andrew G.
    Helliwell, Philip S.
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [4] TIME TO RESPONSE FOR CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB, ADALIMUMAB OR PLACEBO
    Gladman, D. D.
    Coates, L. C.
    Wu, J.
    Fallon, L.
    Hsu, M. A.
    Bushmakin, A. G.
    Bacci, E.
    Cappelleri, J. C.
    Helliwell, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1681 - 1681
  • [5] Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
    Dafna D. Gladman
    Laura C. Coates
    Joseph Wu
    Lara Fallon
    Elizabeth D. Bacci
    Joseph C. Cappelleri
    Andrew G. Bushmakin
    Philip S. Helliwell
    Arthritis Research & Therapy, 24
  • [6] Time to Response for Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Tofacitinib, Adalimumab, or Placebo
    Gladman, Dafna
    Coates, Laura
    Wu, Joseph
    Fallon, Lara
    Hsu, Ming-Ann
    Bushmakin, Andrew
    Bacci, Elizabeth
    Cappelleri, Joseph
    Helliwell, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [7] PATIENTS REPORTED OUTCOMES (PROS) IN PSORIATIC ARTHRITIS (PSA) WITH AXIAL INVOLVEMENT
    Vorobyova, Lyubov
    Korotaeva, Tatiana
    Loginov, Elena
    Korsakova, Yulia
    Gubar, Elena
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [8] Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: Results from two phase 3 studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose
    Mease, Philip
    Gladman, Dafna
    Hendrikx, Thijs
    Graham, Daniela
    Wu, Joseph
    Chen, Linda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB109 - AB109
  • [9] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Strand, V.
    de Vlam, K.
    Covarrubias-Cobos, J. A.
    Mease, P. J.
    Gladman, D. D.
    Hendrikx, T.
    Kudlacz, E.
    Graham, D.
    Wu, J.
    Chen, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1335 - 1336
  • [10] Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose A.
    Mease, Philip J.
    Gladman, Dafna D.
    Hendrikx, Thijs
    Kudlacz, Elizabeth
    Graham, Daniela
    Wu, Joseph
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345